Search Results

There are 1184797 results for: content related to: Response Letter to Finucane

  1. N-succinylaspart-1-yl celecoxib is a potential colon-specific prodrug of celecoxib with improved therapeutic properties

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 5, May 2012, Pages: 1831–1842, Yonghyun Lee, Jeongyun Kim, Hyunjeong Kim, Sookjin Kang, Jeong-Hyun Yoon, Dae-Duk Kim, Young Mi Kim and Yunjin Jung

    Version of Record online : 14 FEB 2012, DOI: 10.1002/jps.23082

  2. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats

    Liver International

    Volume 29, Issue 1, January 2009, Pages: 25–36, Jun Yu, Alex Y. Hui, Eagle S. H. Chu, Minnie Y. Y. Go, Kin F. Cheung, Chung W. Wu, Henry L. Y. Chan and Joseph J. Y. Sung

    Version of Record online : 23 APR 2008, DOI: 10.1111/j.1478-3231.2008.01760.x

  3. Cancer cell killing by Celecoxib: Reality or just in vitro precipitation-related artifact?

    Journal of Cellular Biochemistry

    Volume 114, Issue 6, June 2013, Pages: 1434–1444, Andrea Sacchetti

    Version of Record online : 16 APR 2013, DOI: 10.1002/jcb.24485

  4. You have free access to this content
    Cyclooxygenase-2 inhibitor suppresses tumour progression of prostate cancer bone metastases in nude mice

    BJU International

    Volume 113, Issue 5b, May 2014, Pages: E164–E177, Marta Garcia, Roberto Velez, Cleofé Romagosa, Blanca Majem, Núria Pedrola, Mireia Olivan, Marina Rigau, Marc Guiu, Roger R. Gomis, Juan Morote, Jaume Reventós and Andreas Doll

    Version of Record online : 14 FEB 2014, DOI: 10.1111/bju.12503

  5. You have full text access to this Open Access content
    Celecoxib extends C. elegans lifespan via inhibition of insulin-like signaling but not cyclooxygenase-2 activity

    Aging Cell

    Volume 10, Issue 3, June 2011, Pages: 506–519, Tsui-Ting Ching, Wei-Chung Chiang, Ching-Shih Chen and Ao-Lin Hsu

    Version of Record online : 7 APR 2011, DOI: 10.1111/j.1474-9726.2011.00688.x

  6. Celecoxib for the treatment of mild-to-moderate depression due to acute brucellosis: a double-blind, placebo-controlled, randomized trial

    Journal of Clinical Pharmacy and Therapeutics

    Volume 40, Issue 4, August 2015, Pages: 441–446, S. Jafari, S.-G. Ashrafizadeh, A. Zeinoddini, M. Rasoulinejad, P. Entezari, S. Seddighi and S. Akhondzadeh

    Version of Record online : 26 MAY 2015, DOI: 10.1111/jcpt.12287

  7. Celecoxib Induces Heme-Oxygenase Expression in Glomerular Mesangial Cells

    Annals of the New York Academy of Sciences

    Volume 1042, Issue 1, May 2005, Pages: 235–245, CHUN-CHENG HOU, SU-LI HUNG, SHU-HUEI KAO, TSO HSIAO CHEN and HORNG-MO LEE

    Version of Record online : 9 JAN 2006, DOI: 10.1196/annals.1338.026

  8. You have free access to this content
    Activation of vascular KCNQ (Kv7) potassium channels reverses spasmogen-induced constrictor responses in rat basilar artery

    British Journal of Pharmacology

    Volume 164, Issue 2, September 2011, Pages: 237–249, Bharath K Mani, Lioubov I Brueggemann, Leanne L Cribbs and Kenneth L Byron

    Version of Record online : 22 AUG 2011, DOI: 10.1111/j.1476-5381.2011.01273.x

  9. You have free access to this content
    Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib

    American Journal of Hematology

    Volume 81, Issue 4, April 2006, Pages: 242–255, Guang-Sen Zhang, Ding-Sheng Liu, Chong-Wen Dai and Rui-Juan Li

    Version of Record online : 20 MAR 2006, DOI: 10.1002/ajh.20542

  10. Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double-blind, placebo-controlled trial

    Bipolar Disorders

    Volume 17, Issue 6, September 2015, Pages: 606–614, Somayeh Arabzadeh, Niusha Ameli, Atefeh Zeinoddini, Farzin Rezaei, Mehdi Farokhnia, Payam Mohammadinejad, Ali Ghaleiha and Shahin Akhondzadeh

    Version of Record online : 20 AUG 2015, DOI: 10.1111/bdi.12324

  11. Celecoxib inactivates epithelial–mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells

    Molecular Carcinogenesis

    Volume 51, Issue 10, October 2012, Pages: 783–795, Claudia Bocca, Francesca Bozzo, Stefania Cannito, Maurizio Parola and Antonella Miglietta

    Version of Record online : 31 AUG 2011, DOI: 10.1002/mc.20846

  12. Credulous Fondness for Celecoxib

    Journal of the American Geriatrics Society

    Volume 60, Issue 11, November 2012, Page: 2190, Thomas E. Finucane

    Version of Record online : 13 NOV 2012, DOI: 10.1111/j.1532-5415.2012.04216.x

  13. Celecoxib Potentiates the Anticancer Effect of Cisplatin on Vulvar Cancer Cells Independently of Cyclooxygenase

    Annals of the New York Academy of Sciences

    Volume 1171, Issue 1, August 2009, Pages: 635–641, Su-Hyeon Kim, Su-Hyeong Kim, Yoo-Choel Song and Yong-Sang Song

    Version of Record online : 15 AUG 2009, DOI: 10.1111/j.1749-6632.2009.04888.x

  14. Plasma protein binding of celecoxib in mice, rat, rabbit, dog and human

    Biopharmaceutics & Drug Disposition

    Volume 20, Issue 6, September 1999, Pages: 293–299, Susan K. Paulson, Todd A. Kaprak, Christopher J. Gresk, Douglas M. Fast, Mike T. Baratta, Earl G. Burton, Alan P. Breau and Aziz Karim

    Version of Record online : 20 JAN 2000, DOI: 10.1002/(SICI)1099-081X(199909)20:6<293::AID-BDD188>3.0.CO;2-X

  15. Dosing Celecoxib in Pediatric Patients With Juvenile Rheumatoid Arthritis

    The Journal of Clinical Pharmacology

    Volume 52, Issue 8, August 2012, Pages: 1134–1149, Sriram Krishnaswami, Matt M. Hutmacher, Jeffery L. Robbins, Akintunde Bello, Christine West and Bradley J. Bloom

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011412184

  16. You have free access to this content
    Oral celecoxib versus oral diclofenac for post-perineal repair analgesia after spontaneous vaginal birth: A randomised trial

    Australian and New Zealand Journal of Obstetrics and Gynaecology

    Volume 48, Issue 1, February 2008, Pages: 71–77, Soo Soo LIM, Peng Chiong TAN, Jayanthi Karen SOCKALINGAM and Siti Zawiah OMAR

    Version of Record online : 11 FEB 2008, DOI: 10.1111/j.1479-828X.2007.00808.x

  17. Mesoporous Calcium Carbonate as a Phase Stabilizer of Amorphous Celecoxib – An Approach to Increase the Bioavailability of Poorly Soluble Pharmaceutical Substances

    Advanced Healthcare Materials

    Volume 2, Issue 11, November, 2013, Pages: 1469–1476, Johan Forsgren, Mattias Andersson, Peter Nilsson and Albert Mihranyan

    Version of Record online : 23 MAY 2013, DOI: 10.1002/adhm.201200391

  18. You have free access to this content
    A Randomized, Clinical Trial Comparing Oral Celecoxib 200 mg, Celecoxib 400 mg, and Ibuprofen 600 mg for Acute Pain

    Academic Emergency Medicine

    Volume 10, Issue 1, January 2003, Pages: 22–30, David F. Salo, Robert Lavery, Vikram Varma, Jennifer Goldberg, Tara Shapiro and Alan Kenwood

    Version of Record online : 28 JUN 2008, DOI: 10.1197/aemj.10.1.22

  19. You have free access to this content
    Evaluation of health-related quality of life of rheumatoid arthritis patients treated with celecoxib

    Arthritis Care & Research

    Volume 13, Issue 2, April 2000, Pages: 112–121, Sean Z. Zhao, Justus I. Fiechtner, Elizabeth A. Tindall, Seema D. Dedhiya, William W. Zhao, Jane T. Osterhaus and Shawn S. Yu

    Version of Record online : 21 MAY 2001, DOI: 10.1002/1529-0131(200004)13:2<112::AID-ANR5>3.0.CO;2-L

  20. Celecoxib prevents curcumin-induced apoptosis in a hematopoietic cancer cell model

    Molecular Carcinogenesis

    Volume 54, Issue 10, October 2015, Pages: 999–1013, Cyril Sobolewski, Florian Muller, Claudia Cerella, Mario Dicato and Marc Diederich

    Version of Record online : 4 MAY 2014, DOI: 10.1002/mc.22169